The role of basal forebrain-derived cholinergic afferents in the development of neocortex was studied in postnatal rats. Newborn rat pups received intraventricular injections of 192 IgG-saporin. Following survival periods ranging from 2 days to 6 months, the brains were processed to document the cholinergic lesion and to examine morphological consequences. Immunocytochemistry for choline acetyltransferase (ChAT) and in situ hybridization for ChAT mRNA demonstrate a loss of ∼75% of the cholinergic neurons in the medial septum and nucleus of the diagonal band of Broca in the basal forebrain. In situ hybridization for glutamic acid decarboxylase mRNA reveals no loss of basal forebrain GABAergic neurons. Acetylcholinesterase histochemistry demonstrates a marked reduction of the cholinergic axons in neocortex. Cholinergic axons are reduced throughout the cortical layers; this reduction is more marked in medial than in lateral cortical areas. The thickness of neocortex is reduced by ∼10%. Retrograde labeling of layer V cortico-collicular pyramidal cells reveals a reduction in cell body size and also a reduction in numbers of branches of apical dendrites. Spine densities on apical dendrites are reduced by ∼20-25% in 192 IgG-saporin-treated cases; no change was detected in number of spines on basal dendrites. These results indicate a developmental or maintenance role for cholinergic afferents to cerebral cortical neurons.
Introduction
The process of development of the cerebral cortex is characterized by a complex series of events that includes formation, migration and differentiation of neurons, and also the formation of afferent and efferent connections (e.g. Uylings et al., 1990; Bock and Cardew, 1995) . While these processes are conceptually distinct, it is becoming clear that some of these developmental events can inf luence the course of other events during maturation. For example, current evidence indicates that developing afferent projections to cerebral cortex can inf luence the morphological differentiation of cortical neurons (Valverde, 1967; Rakic, 1979; Hillman, 1988; Mattson, 1988) .
Subcortical afferents to cerebral cortex derive mainly from dorsal thalamus, but others originate from brain stem monoaminergic and basal forebrain cholinergic systems (Foote and Morrison, 1987; Mesulam et al., 1983) . The possible roles of these non-thalamic afferents, not only in normal functioning of the mature cerebral cortex but also in its development, have been the focus of considerable interest (Foote and Morrison, 1987; Coyle and Yamamura, 1976; Ebersole et al., 1981; Lidov and Molliver, 1982) . In particular, basal forebrain cholinergic systems have received a great deal of attention in recent years (Divac, 1975; Wenk et al., 1980; Bigl et al., 1982) . Because of evidence that basal forebrain cholinergic projections to cerebral cortex may play a role in the maintenance of normal cortical neuronal structure and function Sengstock et al., 1992; Cullen et al., 1997) , we became interested in whether the absence of cholinergic afferents to cortex during development might result in altered development of cerebral cortical neurons.
In the past, it has been difficult to selectively eliminate basal forebrain cholinergic neurons. These cells are intercalated within several different nuclear groups that comprise the basal forebrain, extending as a population from the medial septum through the diagonal band to the substantia innominata and medial globus pallidus (Divac, 1975; McKinney et al., 1983; Mesulam et al., 1983) . Within any particular nuclear group, the cholinergic neurons constitute only a fraction of the total neuronal population. Therefore, results from studies using traditional lesion techniques, including electrolytic and excitatory amino acid induced lesions, are difficult to interpret because of their inherent lack of selectivity. Recently, however, Wiley et al. (1991) have introduced an immunolesioning technique in which saporin, a plant-derived ribosome inactivating protein, has been linked to an antibody to the low-affinity neurotrophin receptor (the p75 receptor) to produce an effective immunotoxin termed 192 IgG-saporin. When this immunotoxin is injected into the brain, it is taken up selectively by nerve growth factor (NGF)-sensitive neurons; within the forebrain it affects almost exclusively the basal forebrain cholinergic neurons (Book et al., 1994) .
In the present project, this 192 IgG-saporin has been used to eliminate most of the basal forebrain cholinergic neuron population early in development. We then examined how the absence of cholinergic innervation affects normal development of neurons of visual cortex. Portions of these data have been presented previously in abstract form (Gallardo et al., 1992; Robertson et al., , 1994 Robertson et al., , 1995 .
chromatography. For injections, the immunotoxin was dissolved in phosphate-buffered normal saline (PBS).
Surgical Procedures
Young rat pups were anesthetized by placing them in shaved ice for 3-5 min on P0 and again on P2. Animals were held under a stereotaxic carrier, and injections of either 192 IgG-saporin in PBS or vehicle alone were made using a Hamilton microsyringe and a 30G needle. The tip of the needle was targeted for the lateral ventricle, 1.5 mm lateral to midline and 0.2 mm anterior to the Bregma skull suture. Using a stereotaxic carrier with a microdrive, the needle was inserted directly through the skin and developing skull, to a depth of 3.0 mm below the surface. Unilateral injections of 100 ng 192 IgG-saporin in 0.5 µl PBS were made on P0 and of 200 ng in 1.0 µl PBS on P2. Injections of saline were made in control animals. The needle was left in place for 30-60 s following the injections.
Animals were placed in a temperature-controlled incubator until they recovered normal temperature and activity, at which time they were coated with vegetable oil and cage litter and returned to the dam. Pups were given s.c. Ringer's/saline solution injections daily, beginning at P1 and ending at P10 or until killed if younger than P10. In most cases, pups were tube fed with kitten milk replacement as needed.
At ages ranging from P4 to 6 months, animals were deeply anesthetized with sodium pentobarbital (60 mg/kg) and perfused transcardially with 4% paraformaldehyde (PA), 0.5% glutaraldehyde and 0.2% picric acid in 0.1 M phosphate buffer (PB) for acetylcholinesterase (AChE) histochemistr y, or 4% PA in PB for all other procedures. For histochemical, immunocytochemical and in situ hybridization procedures, brains were cryoprotected in 30% sucrose in PB for 48 h before they were cut on a freezing microtome at a thickness of 50 µm.
Acetylcholinesterase Histochemistry
Sections from all experimental and control animals were processed for AChE histochemistry by a procedure modified slightly from that of Tago et al. (1986) . Sections were rinsed in three changes of 100 mM maleate buffer (pH 6.0) for 10 min each, and then incubated in 50 ml of maleate buffer, with 30 µl 86.5 mM acetylthiocholine, 100 µl 30 mM iso-OMPA and 500 µl Karnovsky and Roots solution (made up from 2.5 ml 100 mM sodium citrate, 5 ml 30 mM copper sulfate, 8 mg potassium ferricyanide and 42.5 ml 100 mM maleate buffer). Sections from animals aged P7 or younger were incubated overnight at 4°C; sections from animals older than P7 were incubated for 4 h at room temperature. After incubation in the dark, the cultures were rinsed in five changes of 50 mM Tris buffer, pH 7.5, and then reacted in 0.05% 3,3′-diaminobenzidine, 0.003% hydrogen peroxide with 0.2% nickel ammonium sulfate in 50 mM Tris buffer for 5-10 min. Sections were rinsed in several changes of 50 mM Tris buffer, mounted on gelatin-coated slides, dehydrated in ethanol and cleared in xylene before coverslipping with DPX.
Choline Acetyltransferase (ChAT) Immunocytochemistry Selected sections from ∼20 experimental and control brains were processed for ChAT immunocytochemistry. Sections were blocked with 3% normal rabbit serum (NRS) for l h at room temperature before incubating overnight at 4°C in goat anti-ChAT (Chemicon A B144P) primary antibody, 1:500 in NRS. Sections were rinsed in PB and then incubated in biotinylated rabbit anti-goat secondary antibody for 1 h at room temperature. Sections were stained according to the Vectastain Elite ABC Kit from Vector Laboratories, using nickel-intensified DA B as the chromagen. Sections were mounted, dehydrated, cleared in xylenes and coverslipped for examination under the light microscope. Counts of ChAT-immunoreactive neurons were made in both hemispheres from at least three sections in each brain; numbers were compared between experimental (192 IgG-saporin-treated) and control (saline-injected) animals. No correction factor was used to compensate for split cells.
In Situ Hybridization
Sections were processed for in situ hybridization, using either colorimetric (four experimental and four control brains) or autoradiographic (11 experimental and 11 control brains) techniques. Animals to be used for the colorimetric procedure were perfused with 4% PA. Sections cut on a freezing microtome at 40-60 µm were stored in the fixative and processed free f loating for ChAT or glutamic acid decarboxylase (GAD) mRNA in situ hybridization. For autoradiographic procedures, animals were killed by decapitation and their brains quickly removed and frozen in isopentane at -20°C. Cryostat sections (20 µm) were mounted onto gelatin and poly-L-lysine-coated slides and kept at -20°C. Sections were post-fixed with 4% PA in 0.1 M PB, pH 7.4 for 1 h at 22°C, then washed in PB, air dried and stored desiccated at -20°C until use.
For ChAT cRNA hybridization, riboprobes were transcribed from the genomic subclone pGSChAT (Lauterborn et al., 1993 (Lauterborn et al., , 1995 , containing a 431 bp cDNA fragment corresponding to nucleotides 268-699 of rat ChAT cDNA (Brice et al., 1989) . For cRNA generation, the construct was digested with PvuII, and antisense transcripts were generated by in vitro transcription using T7 RNA polymerase in the presence of either [ 35 S]UTP or digoxigenin (DIG)-UTP. For GA D cRNA hybridization, riboprobes were prepared from genomic subclone pBSGAD (Benson et al., 1992) , which corresponds to bases 1324-1683 of cat GAD67 cDNA (Erlander and Tobin, 1991; Benson et al., 1992) . Antisense RNA was transcribed from BamHI-digested pBSGAD using T7 RNA polymerase in the presence of either 35 S-labeled or DIG-labeled UTP. Colorimetric in situ hybridization was carried out as previously described by Lauterborn et al. (1993) . Brief ly, free-f loating sections were treated with proteinase K (1 µg/ml), and incubated in a hybridization buffer (50% formamide, 10% dextran sulfate, 0.7% Ficoll, 0.7% polyvinyl pyrrolidone, 0.7% bovine serum albumin, 0.15 mg/ml yeast tRNA, 0.33 mg/ml denatured salmon sperm DNA, 40 µM dithiothreitol) containing the DIG-cRNA (diluted 1:1000) at 60°C for 30-36 h. Sections were then washed in 50% formamide and 2 × SSC (2 × SSC = 0.3 M NaCl and 0.03 M sodium citrate, pH 7.0), treated with ribonuclease A (10 µg/ml), and washed through descending concentrations of SSC buffer to a final wash in 0.1 × SSC. Tissue was then incubated in alkaline phosphate-conjugated sheep anti-DIG antisera (1:1000) in 100 mM Tris-HCl, 150 mM NaCl containing 2% normal sheep serum, 0.05% Triton X-100, and 10 mM sodium thiosulfate, at room temperature overnight. The colorimetric reaction was carried out in 100 mM Tris-HCl, 100 mM NaCl, 50 mM MgCl2 containing nitroblue tetrazolium (0.34 mg/ml), 5-bromo-4-chloro-3-indolyl phosphate (0.18 mg/ml) and levamisole (0.24 mg/ml) in the dark for 4-6 h at room temperature. Sections were mounted onto gelatincoated slides, dehydrated and defatted through alcohol and histoclear, and coverslipped.
Tissue sections were processed for radiographic in situ hybridization by a modification of the method described by Simmons et al. (1989) . Brief ly, sections were pretreated with proteinase K (0.1 mg/ml), acetylated, dehydrated through ethanol (50, 75, 95 and 100%) and air dried. Sections were then incubated for 18 h at 60°C, in hybridization solution (50% formamide, 10% dextran sulfate, 0.02% Ficoll, 0.02% polyvinyl pyrrolidone, 0.02% bovine serum albumin, 500 mg/ml tRNA, 10 mM dithiothreitol, 0.3 M NaCl, 10 mM Tris pH 8.0, 1 mM EDTA pH 8.0) containing 35 S-labeled sense or antisense riboprobes (1 × 10 7 c.p.m./ml).
After the hybridization, sections were incubated with ribonuclease A (20 mg/ml) for 30 min at 37°C, followed by 4 × 5 min high-stringency washes. Tissue sections hybridized with 35 S-labeled riboprobes were dehydrated and apposed to β-max film for several days. Following film development, sections were dipped in liquid NTB2 emulsion, diluted 1:1 with distilled water. A fter 3 weeks, slides were developed in Kodak D-19, fixed, counterstained with cresyl violet, coverslipped and analyzed using transillumination microscopy. Cell counts were obtained from dipped slides. In all cases, littermate experimental and control animals were processed together. Labeled cells in both hemispheres from each brain were counted by an experienced obser ver. Counts were made from 2-4 sections through the basal forebrain of each brain and comparisons made between hemispheres that received 192 IgG-saporin treatment and the contralateral hemisphere, as well as between control (saline injected) and experimental cases.
DiI Preparations
Brains of 16 experimental and 12 control animals were processed for retrograde labeling of cortical pyramidal cells (Godement et al., 1987) . Animals were perfused at P4-P10 and brains were post-fixed in 4% PA for 2-7 days. After post-fixation, the superior colliculi of each brain received symmetric bilateral placements of small crystals of the carbocyanine dye DiI (1,1′-dioctadecyl-3,3,3′,3-tetramethylindocarbocyanine perchlorate; Molecular Probes, Eugene, OR) for retrograde labeling of layer V pyramidal cells in visual cortex. Placement of the DiI crystals was done by using fine glass pipettes under a dissection microscope. Tissue with DiI placements was held in PB/0.2% sodium azide solution at 37°C for 6-8 weeks. The tissue was then either sectioned on a vibratome or stored in 2% PA in PB at 4°C until sectioned. Wet mounted sections were examined using a BioRad MRC-600 laser confocal microscope, and Z-series of optical sections were compressed to two-dimensional images. Measurements of distance from the soma to the pial surface, cross-sectional areas of labeled neuronal somata and numbers of dendritic branches were made using COMOS software. Counts of spines on primary and secondary dendrites were made from confocal images.
Anterograde Transneuronal Transport of WGA-HRP Ten animals treated with 192 IgG-saporin and four controls were used for these studies. At ages P7βP10, animals were anesthetized using a combination of xylazine (Rompun, 1.5 mg/kg, i.p.) and ketamine hydrochloride (Ketaset, 15 mg/kg). Wheat germ agglutinin conjugated to horseradish peroxidase (WGA-HRP) was suspended in PBS; injections of 100 nl-1 µl of WGA-HRP solutions (containing 2-50 µg WGA-HRP, at 2-5%) were made into the vitreous body using a micropipette attached to a Hamilton microsyringe. Following post-injection survival times of 2-3 days, animals were deeply anesthetized and perfused with a solution containing 1.5% glutaraldehyde and 1.0% PA in 0.1 M PBS, pH 7.4. Frozen or vibratome sections of 40-60 µm were processed for HRP histochemistry, using the histochemical method of Mesulam (1982) with tetramethyl benzidine (TMB) as the chromagen. Other sections were processed for AChE histochemistry, as described above, or for Nissl staining.
Statistical Analyses
Differences between the 192 IgG-saporin-treated cases and control cases across time points were assessed by analysis of variance. In some cases, the two groups were compared at a single time point by use of Student's t-test. Comparison of basal forebrain cholinergic cell numbers in experimental and control groups were made using the Mann-Whitney U-test.
Results

General Effects of 192 IgG-Saporin Treatment
Intraventricular administration of 192 IgG-saporin to neonatal rat pups resulted in decreased body weight during the postnatal period (Fig. 1A) . The treated animals typically reduced feeding and were tube fed a milk replacement formula in addition to s.c. injections of Ringer's/saline. Even with tube feeding, by P6 the experimental animals weighed significantly less than controls (F = 29.2; P < 0.0001). Animals older than 6-7 days typically returned to nursing, but reduced body weight was evident until at least 1 month of age.
Evidence of the injection needle track was visible with short survival times (2-3 days) but no long-term evidence of injection damage was detected.
Reduction in Numbers of Basal Forebrain Cholinergic Neurons
Neonatal treatment with 192 IgG-saporin resulted in reduced numbers of basal forebrain neurons that express the cholinergic phenotype. Figure 2 presents photomicrographs of ChATimmunoreacted sections through the basal forebrain of a control animal injected with saline ( Fig. 2A ) and littermate experimental animals injected with 192 IgG-saporin on P0 and P2 (Fig. 2B) ; all animals were perfused on P8. Note the distinct loss of ChAT-positive neurons in the diagonal band, both the vertical and the horizontal limbs, and the apparent atrophy of some of the remaining ChAT-positive neurons. Reduction in numbers of ChAT-positive neurons was most prominent in the medial septum and diagonal band regions, where a cell loss of 70-85% was detected; numbers of cells were also reduced in the substantia innominata and medial globus pallidus, where cell losses of 50-75% were detected. As shown in Figure 2C , the hemisphere that received the unilateral injections of 192 IgG-saporin displayed a greater reduction of ChAT-positive neurons than did the untreated hemisphere, although considerable variability was seen in the involvement of the contralateral hemisphere. A reduction in the number of ChATpositive neurons in the lateral portion of the caudate-putamen complex also was noted (not illustrated).
Reduction in the numbers of ChAT-positive or AChE-positive neurons in the diagonal band region of experimental cases was detected as early as 2 days after the second injection (on P4), appeared to be maximal by about P8 (when cell loss reached ∼70-80% in the treated hemispheres), and was evident in animals as old as 6 months of age (the oldest animals included in this analysis).
The obser vation of reduced numbers of ChAT-immunoreactive neurons in the diagonal band in the experimental animals was supported by results from in situ hybridization studies of ChAT mRNA. Figure 3 presents photomicrographs of sections processed for colorimetric (Fig. 3A ,B) and autoradiographic (Fig. 3E ,F) localization of ChAT mRNA. These illustrate the normal pattern of ChAT mRNA-positive neurons in the horizontal limb of the diagonal band in saline-injected control animals (Fig. 3A ,E) and the marked reduction of labeled cells in the 192 IgG-saporin-treated animals ( Fig. 3B,F) . Cell counts of labeled cells in the nucleus of the diagonal band demonstrate a mean loss of 76% of ChAT mRNA-positive neurons in 192 IgG-saporin-treated animals at P8 (n = 7 experimentals and 7 controls) and a mean loss of 68% of cells at P21 (n = 4 experimentals and 4 controls). Reductions of cell numbers in the 192 IgG-saporin-treated cases was significant both for ChAT mRNA-positive cells in the diagonal band (U = 2; P < 0.001) and in the medial septum (U = 1.5; P < 0.001). As with the immunocytochemical studies, the reduction in numbers of ChAT mRNA-positive neurons was greater in the 192 IgG-saporininjected hemispheres; numbers of positive neurons in the contralateral hemispheres varied from almost normal (reductions of 5-20% of cells, relative to controls) to reductions almost equivalent to the injected hemispheres. It is important to point out that the near-normal patterns of ChAT-positive neurons in the hemisphere contralateral to 192 IgG-saporin injections in at least some of the cases indicates that the decrease in cholinergic markers in the affected hemispheres is not simply due to malnutrition and decreased weight gain (Fig. 1) .
The effect of 192 IgG-saporin on cholinergic neurons appears specific, as neighboring sections processed for in situ hybridization for GAD mRNA revealed no difference between the experimental and saline-injected control animals (Fig. 3C,D) .
As in the immunocytochemical studies, the numbers of ChAT mRNA-positive neurons in the lateral portion of the caudateputamen were also reduced (not illustrated).
Reduction of AChE-positive Axons in Cortex
Neonatal treatment with 192 IgG-saporin results in marked loss of AChE-positive axons in cortex. AChE histochemistry was chosen because expression of AChE has been shown to be a valid marker for basal forebrain cholinergic neurons, including their axons (Levey et al., 1983) and its use is more reliable than ChAT immunocytochemistry. Figure 4 compares photomicrographs of visual cortical sections processed for AChE histochemistry taken from a saline-injected control (Fig. 4A ) and an experimental 192 IgG-saporin-treated littermate (Fig. 4B) ; both animals were perfused at P10. Note the striking reduction in numbers of AChE-positive fibers in the experimental case. Loss of AChEpositive fibers occurred in all cortical layers, without clear laminar patterns. The remaining AChE-positive axons, when encountered, usually were in layer I or in deep layer VI. These data were difficult to quantify, but measurements of total length of AChE-positive fibers in cortex (Kimm et al., 1995) revealed a reduction of >95% of these axons in the affected regions of the hemisphere. The reduction of AChE-positive axons in cortex was greater in the hemisphere injected with saporin than in the contralateral hemisphere, although considerable variation occurred in the contralateral hemispheres of different cases. For example, Figure 4D illustrates AChE staining in the contralateral hemisphere of this saporin-treated case; the pattern of AChE-positive axons is similar to that from a control animal (Fig.  4A) . Figure 4C presents a Nissl stained section from the saporin-treated case, which indicates the relatively normal lamination pattern.
Reduction in numbers of AChE-positive axons occurred throughout the cerebral mantle of the 192 IgG-saporin-treated hemisphere, but was most striking in medial regions. Medial cortex, from the level of the genu of the corpus callosum and extending posteriorly to retrosplenial and visual areas, consistently showed the greatest reduction in labeled axons. More lateral neocortex, extending into pyriform cortex, showed progressively less marked reductions in AChE staining.
Reduction of AChE-positive axons is apparent as early as 2 days following the injection paradigm (at P4) and appears to be permanent. Figure 5 shows examples of AChE staining in visual cortical sections from animals killed at 4 days of age (Fig. 5A,B ) and at 40 days of age (Fig. 5C,D) , both ages show a marked reduction in numbers of AChE positive axons in the medial cortex of saporin treated animals. At extended times of 3-6 months of age (not illustrated) the saporin-treated hemispheres still show marked loss of AChE-positive axons.
Cortical Morphological Features
Early treatment with 192 IgG-saporin resulted in cortex that was reduced in size. The cerebral hemispheres that received 192 IgG-saporin injections are reduced both in thickness and in medial-lateral extent, as compared to the contralateral uninjected hemisphere. Thickness of occipital cortex, from the pial surface to the white matter, of 192 IgG-saporin-treated and saline-treated controls was measured at the level of the splenium of the corpus callosum and data are presented in the histograms of Figure 1B . These data indicate that the 192 IgG-saporintreated animals display a reduced cortical thickness across all ages (F = 22.5; P < 0.001); a difference is first detected by P8 and continues until at least 3 months of age. Considerable variation occurred in the thickness of cortex in the contralateral hemisphere. Hemispheres with marked loss of AChE-positive fibers displayed a greater reduction in cortical thickness than did hemispheres with near-normal patterns of AChE fibers.
Layer V pyramidal neurons in visual cortex (area 17) were retrogradely labeled by DiI placements in the superior colliculi in brains of saline-treated control animals and of 192 IgG-saporin-treated experimental animals. Littermates, injected with either saline or saporin as infants, were processed together after being killed at P4, P6, P8 or P10. Examples of retrogradely labeled neurons from animals killed at P6 are shown in the f luorescence confocal photomicrographs of Figure 6A ,B; higher magnification images of the apical dendrites are presented in Figure 6C ,D. This was one of the more clearly affected cases. Note that the pyramidal cell from the saporin-treated animal (Fig.  6B ) appears slightly smaller and with an apical dendrite that is shorter and displays fewer branches than the comparable neuron from the saline-treated animal. No differences were detected in number of primary or of secondary basal dendrites. Further, the apical dendrite of the saporin-treated animal displays fewer spines than does the apical dendrite of the saline-treated control. These qualitative impressions are supported by quantitative analyses. Figure 7 presents quantitative data from morphological analyses of labeled neurons of animals killed at P4 (2 days following the second set of injections), P6 and P8, and compares values obtained from saporin-treated and control hemispheres. Retrogradely labeled layer V pyramidal neurons from 192 IgG-saporin-treated hemispheres showed reduced somatal cross-sectional areas (F = 26.1; P < 0.001). Differences between experimentals and controls were detected at P6 and P8 but not at P4 (Fig. 7A) . The lengths of apical dendrites appeared slightly reduced in the experimental cases although analysis of variance performed on these data indicates no overall signficant difference between the experimentals and controls. However, on P8, Student's t-test revealed that the difference in means (508 for control; 463 for saporin treated) is significantly different (t = 8.1; P < 0.05). As shown in Figure 7C , the number of primary branches off the apical dendrites was reduced in the saporintreated cases, compared to the controls (F = 13.2; P < 0.01). As with cell body size, the difference in dendritic branches was not apparent at P4, but was detected at P6 and P8.
The 192 IgG-saporin-treated hemispheres also displayed reduced numbers of dendritic spines on layer V pyramidal neurons, as illustrated in Figure 6C ,D, and by the quantitative data presented in Figure 8 . Differences in numbers of apical dendritic spines between the experimental and control groups were not detected at P4, but were significant at P6 and P8. The apical dendrites of 192 IgG-saporin-treated cases displayed reduced numbers of spines along the middle of the apical dendrite ( Fig. 8A ) (F = 17.1; P < 0.001) and along the tips of the apical dendrites as they branch in the superficial cortical layer (Fig. 8B ) (F = 10.3; P < 0.01). No difference between experimentals and controls was detected in spine frequency of basal dendrites (Fig. 8C) at any age.
Thalamocortical Development
Evidence presented above indicates that early treatment with 192 IgG-saporin results in reduced dendritic branching and spine number in neocortex. The current working hypothesis is that cholinergic inner vation plays an important, and possibly direct, role in dendritic development. However, previous work (Höhmann et al., 1991a,b) suggested that early basal forebrain lesions disrupt development of thalamocortical connectivity. Because a normal thalamocortical projection, or the neural activity it mediates, is known to be important for development of cortical neurons (Valverde, 1967; Greenough and Volmar, 1973; Harris and Woolsey, 1981; Greenough and Chang, 1988; Windrem and Finlay, 1991) experiments were undertaken to determine if the 192 IgG-saporin-induced lesions affected thalamocortical development. Figure 9 summarizes these results. The geniculocortical projection to visual cortex (area 17) was labeled by anterograde transneuronal transport of WGA-HRP for both saline-injected control animals (Fig. 9A,C) and in animals treated neonatally with 192 IgG-saporin (Fig. 9B,D) . The areal and the laminar distributions of HRP labeling are similar in both cases; thus, these data do not support the contention that early cholinergic lesions disrupt thalamocortical development.
Discussion
The results of these studies demonstrate the efficacy of early treatment with 192 IgG-saporin as a means of reducing the numbers of basal forebrain cholinergic neurons and their axonal projections to neocortex, and also demonstrate that this early treatment results in retarded development of cortical pyramidal cells. 
Immunolesions of the Basal Forebrain Cholinergic System
One common approach employed by developmental neurobiologists has been to remove a structure during early development and determine the consequences of this manipulation. This approach has been applied to studies of the development of the cerebral cortex, and investigators have used a variety of lesion techniques to remove particular sources of afferents (e.g. Felten et al., 1982; Miller et al., 1991; Höhmann et al., 1988 Höhmann et al., , 1991a Robertson et al., 1988) . The lesion approach has been used in studies of the role of the basal forebrain cholinergic system in cerebral cortical development (Höhmann et al., 1988 (Höhmann et al., , 1991a Robertson et al., 1988; Sengstock et al., 1992) ; however, this system poses special challenges to the lesion technique. In the rat ner vous system, basal forebrain cholinergic neurons are scattered through several different cytoarchitectonically defined nuclear groups of the basal forebrain, including the medial septum, diagonal band, substantia innominata, lateral hypothalamus and medial globus pallidus (Divac, 1975; Wenk et al., 1980; Bigl et al., 1982; McKinney et al., 1983; Mesulam et al., 1983) . Work by Gritti et al. (1993 Gritti et al. ( , 1997 has demonstrated that the cholinergic neurons comprise only a fraction (20-30%) of the total number of neurons in any particular region, so that methods of electrolysis or exposure to excitatory amino acids invariably result in lesions that involve non-cholinergic as well as the targeted cholinergic neurons. GABAergic neurons are found with at least least twice the frequency of cholinergic neurons in these basal forebrain nuclei, and still another substantial population of neurons remains unidentified (Peterson et al., 1987; Gritti et al., 1993 Gritti et al., , 1997 . The possibility of some damage to non-cholinergic neurons cannot be ruled out completely, although the present in situ hybridization data indicate no loss of the GABAergic neurons.
Others have developed phenotype-specific lesion techniques (e.g. Armstong and Pappas, 1991) , but the most effective approach to eliminating basal forebrain cholinergic neurons has been the introduction of immunolesioning by Wiley, Lappi and co-workers (Wiley et al., 1991; Book et al., 1994; Heckers et al., 1994; Lee et al., 1994; Rossner et al., 1995; Waite et al., 1995; Leanza et al., 1996; Pappas et al., 1996; Milner et al., 1997) . In this method, the plant-derived protein saporin is conjugated to the 192 IgG, an antibody to the low-affinity p75 neurotrophin receptor. In principle, the 192 IgG binds to the p75 receptor; the entire complex of p75 receptor, antibody and saporin, perhaps along with the TrkA receptor, are taken into the cell and transported retrogradely to the soma (Wiley et al., 1991; Wiley and Lappi, 1993; Curtis et al., 1995) . Saporin, by inactivating ribosomes and hence shutting down protein synthesis, leads to the death of the cell. Several studies have demonstrated that, within the forebrain, this immunolesioning method is specific to basal forebrain cholinergic neurons (Wiley et al., 1991; Book et al., 1994; Heckers et al., 1994; Lee et al., 1994; Torres et al., 1994; Rossner et al., 1995; Waite et al., 1995; Leanza et al., 1996) . Evidence presented here demonstrates a selective loss of cholinergic neurons in the basal forebrain and no detectable effect on GABAergic neuronal populations in the same regions, corroborating the findings of others (Lee et al., 1994; Torres et al., 1994) . This technique is dependent upon the presence of the p75 receptor, which appears to be present in these neurons at the time of toxin administration (Koh and Loy, 1989; Lu et al., 1989) . This empirical demonstration of specificity is not easily interpreted in light of evidence that the p75 receptor is expressed by many cell types other than the basal forebrain cholinergic neurons (Bothwell, 1995; Carter and Lewin, 1997) . Reasons why we did not detect losses in other populations of neurons may be that the subpopulation of these neurons that express the receptor is too small, that the 192 IgG-saporin did not diffuse far enough to affect these cells, that we have not selected the appropriate cell population marker to detect cell loss, or that the presence of the p75 receptor alone is not enough for entry of the saporin into the cell. Presence of the TrkA receptor along with the p75 receptor may be necessary for the 192 IgG-saporin to be taken into the cell and retrogradely transported.
It is of interest that the present experiments detected a loss not only of cholinergic neurons in basal forebrain, but also a loss of some of the cholinergic local circuit neurons of the striatum. Available evidence indicates that striatal cholinergic neurons express the p75 receptor (Pioro and Cuello, 1990) and are dependent on NGF early in development (Knusel et al., 1994) . However, not all striatal neurons were lost in the saporin-treated cases; the sparing of some of these neurons is likely due to limited diffusion of the 192 IgG-saporin and hence the limited access of striatal cholinergic neurons to the toxin.
A marked reduction of cholinergic neurons in the basal forebrain results from intraventricular injections of 192 IgGsaporin. It is not completely clear whether the loss of cholinergic neurons represents death of those cells or a down-regulation of the cholinergic markers (ChAT protein, AChE activity or ChAT mRNA). However, Book et al. (1994) demonstrated a marked loss of basal forebrain cholinergic neurons previously retrogradely labeled following injections of tracers into cerebral cortex, indicating that the neurons had died following 192 IgG-saporin treatment. Further, the present results demonstrate that the loss of cholinergic markers extends for at least 6 months, suggesting that many of the basal forebrain neurons had died. However, whether the cholinergic cells are dead or only dormant, the result would be the same -a functional cholinergic denervation of cortex.
It is not clear whether the injected 192 IgG-saporin is taken up by axon terminals in cortical regions or whether the toxin is taken up by dendrites and somata of cholinergic neurons within the basal forebrain. The p75 receptors are expressed over much of the cholinergic neuron's surface (Chao, 1994; Chao and Hempstead, 1995) and presumably uptake could occur at any site. However, Heckers et al. (1994) have shown the important role of retrograde transport in the action of the immunotoxin by demonstrating that co-injecting colchicine blocks the effect of 192 IgG-saporin; this finding supports the notion that the 192 IgG-saporin is taken up by axon terminals and transported retrogradely to the somata.
Is the Cholinergic Lesion the Primary Cause of Morphological Consequences in Cortex?
Treatment of neonatal rats leads to clear morphological changes in developing cerebral cortex. A lthough we favor an interpretation that the differences in development of cortical morphological features result from loss of cholinergic afferents, other explanations are also possible, including a direct effect of the 192 IgG-saporin on the cortical neurons. However, we do not believe the toxin is having a direct effect on cortical neurons for the following reasons. First, the cortical pyramidal neurons are not known to express the p75 receptor and hence should not be affected by this immunolesioning technique. Second, our recent attempts to identify the cells that are likely to be affected by the toxin have employed a conjugate of 192 IgG and a f luorescent marker (Ha et al., 1997) . Injection of this compound, in situations that parallel the injection of the 192 IgG-saporin, results in clear labeling of basal forebrain cholinergic neurons but no evidence of labeling of cortical pyramidal cells (Ha et al., 1997) . These data suggest that the 192 IgG-saporin does not enter cortical neurons and is therefore unlikely to result directly in cortical cell atrophy.
Another possible explanation is that the early cholinergic lesion reduces development of thalamocortical projections (Höhmann et al., 1991a,b) and the retarded dendritic development of cortical pyramidal cells results directly from the reduced thalamocortical input and only indirectly from the cholinergic insult. This possibility is unlikely because injections of 192 IgG-saporin that result in markedly reduced cholinergic innervation of neocortex are shown here not to disrupt normal patterns of development of geniculocortical projections (Kageyama et al., 1990; Kageyama and Robertson, 1993) . Thus, the reduction of thalamocortical projections is not an intermediate step between the cholinergic insult and decreased dendritic branching.
The finding that 192 IgG-saporin-treated animals show reduced weight gains may suggest that the treatment simply produces sick animals, and that malnutrition associated with reduced feeding may account for the reduced cortical neuronal development. This is particularly important in light of evidence that early malnutrition can produce cerebral cortex with reduced thickness and reduced dendritic branching (Carughi et al., 1990; Cordero et al., 1993; Fernandez et al., 1993 Fernandez et al., , 1997 . While this criticism must be taken seriously, the best evidence against the malnutrition hypothesis is provided by the several cases in which the effects of saporin treatment are largely ipsilateral. That is, the hemisphere contralateral to the 192 IgG-saporin injection in several cases displayed near-normal numbers of basal forebrain cholinergic neurons and near-normal patterns of AChE-stained cholinergic axons in cortex, while the injected hemisphere showed marked cholinergic defects (e.g. Fig. 4) . Thus, the cases in which the loss of cholinergic markers in 192 IgG-saporin-treated hemispheres are associated with reduced weight gain often display contralateral hemispheres that show normal patterns of cholinergic innervation, normal thickness of cortex and normal patterns of dendritic development. While these data demonstrate that reduced cholinergic innervation and abnormal cortical dendritic development are not directly the result of malnutrition, the issue of whether cholinergic deafferentation interacts with malnutrition to produce the retarded dendritic development remains unresolved. That is, malnutrition might 'prime' the developing cortex so that pyramidal neurons are more susceptible to loss of cholinergic afferents. Arguing against this possibility, however, are several cases that have normal weight gain but still express marked cholinergic loss and retardation of dendritic development. Further, it is of interest that malnutrition has been reported to affect preferentially the basal dendrites of pyramidal cells (Cordero et al., 1993; Fernandez et al., 1993) but the 192 IgG-saporin treatments here affected apical dendrites and had no detectable inf luence on branching of basal dendrites. Therefore, we believe the morphological consequences of 192 IgG-saporin treatment are very unlikely to be due to general systemic effects. The most parsimonious explanation is that the morphological changes are a consequence of loss of cholinergic afferents.
Reduction of Cholinergic Innervation of Cerebral Cortex
Neonatal treatment with 192 IgG-saporin resulted in a marked loss of basal forebrain cholinergic neurons and a loss of cholinergic innervation of cerebral cortex, corroborating results presented by others (Wiley et al., 1991; Book et al., 1994; Heckers et al., 1994; Rossner et al., 1995; Wenk et al., 1994; Waite et al., 1995; Leanza et al., 1996) . Basal forebrain cholinergic projections to cortex do not display strong laminar patterns of termination (Luiten et al., 1987 (Luiten et al., , 1989 Lysakowski et al., 1989; Robertson et al., 1991; Calarco and Robertson, 1995) and the present data indicate no layer-specific loss of afferents following 192 IgG-saporin treatment.
The present study focused on visual cortex for two principal reasons. First, previous studies have demonstrated that basal forebrain cholinergic systems develop relatively late (Armstrong et al., 1987; Vaca, 1988; Brady et al., 1989; Gould et al., 1991; Henderson, 1991; Thal et al., 1991) with basal forebrain-derived cholinergic afferents not arriving in visual cortex until after the time of birth (Dinopoulos et al., 1989; Dori and Parnavelas, 1989; Kiss and Patel, 1992; Calarco and Robertson, 1995) . Thus, treatments with 192 IgG-saporin beginning on the day of birth are likely to result in a visual cortex that never receives a basal forebrain derived cholinergic projection. Secondly, our studies characterizing the cholinergic deficit demonstrated that the medial cortical regions, including visual cortex, were affected by the saporin treatment to a greater extent than lateral cortical regions. Whether this regional difference stems from differential access to the 192 IgG-saporin by the cholinergic axon terminals in cortex or by the cell bodies of origin in the basal forebrain is not entirely clear. Visual cortex receives most of its cholinergic afferents from the nucleus of the diagonal band (McKinney et al., 1983; Lamour et al., 1984; Robertson et al., 1988; 1990; Calarco and Robertson, 1995) . The proximity of the nucleus of the diagonal band to the cerebral spinal f luid, and hence to the injected 192 IgG-saporin, may also be a factor in the prominent loss of these cholinergic neurons and consequently the prominent loss of AChE-positive axons in visual cortex. The observation that some neurons within the diagonal band appear quite healthy would fit with the notion that these neurons send their axons to the olfactory bulb (Mesulam et al., 1983) and these axons do not pick up or transport the injected toxin.
The study of AChE-positive basal forebrain afferents is somewhat complicated by the fact that developing thalamocortical axons are also AChE positive during the early postnatal period (Robertson, 1987; Robertson et al., 1988; and these AChE-positive thalamocortical axons appear not to be affected by the saporin treatment. The loss of AChEpositive basal forebrain-derived axons could still be determined conclusively against the background of AChE-positive thalamocortical axons for several reasons. First, although both thalamocortical and basal forebrain axons are AChE positive, they display quite different morphological features and hence the two populations are easily distinguishable (Robertson et al., 1988 (Robertson et al., , 1991 Hanes et al., 1994) ; injections of 192 IgG-saporin affected only the basal forebrainderived AChE positive axons. Second, the AChE-positive thalamocortical axons are restricted to cortical area 17 and the loss of AChE-positive basal forebrain-derived axons could also be detected in adjacent area 18. Third, thalamocortical axons are AChE positive only during a limited developmental window (Robertson, 1987; , and loss of AChE-positive basal forebrain axons was detected in animals as old as 6 months of age. Overall, results from animals of different ages demonstrate that early treatment with 192 IgG-saporin reduces AChE-positive axons from basal forebrain, but not the AChE-positive thalamocortical axons. Use of ChAT immunocytochemistry may have provided a marker less confounded by the transient expression of AChE in thalamocortical axons, but, at least in our hands, the AChE histochemical techniques are more reliable and consistently produce high-quality labeling of cortical cholinergic axons.
Consequences of Reduced Cholinergic Innervation of Cerebral Cortex
Basal forebrain cholinergic neurons send axons to much of the cerebral cortex. Although directly relevant data are sparse, it is likely that many and probably most cortical neurons receive some cholinergic inner vation (Wainer, 1984; Houser et al., 1985) . It remains unclear whether cholinergic afferents have trophic effects on the development of cortical neurons. Work by Höhmann et al. (1988 Höhmann et al. ( , 1991a showed that placement of lesions in basal forebrain nuclei of neonatal mice affected cortical development by retarding the formation of mature laminar patterns and by retarding the dendritic development of cortical pyramidal cells. These investigators noted that the consequences of early basal forebrain lesions are not, however, permanent as the morphological features of the affected hemisphere are eventually similar to those of the control hemisphere. One possible explanation for the 'catch up' phenomenon is that the basal forebrain lesions were incomplete, and remaining cholinergic neurons may have sprouted axons to innervate the affected cortical regions (Farris et al., 1993) .
The present data corroborate the results of Höhmann and colleagues by demonstrating both general and specific sequelae of early cholinergic lesions. A slight reduction of thickness of affected cortex was seen, without evidence of any layer-specific loss. This reduction in thickness probably ref lects a decrease in neuropil that resulted from not only the loss of cholinergic afferents (which would account for only a very minor fraction of the total neuropil) but also the reduction in dendrites of affected cortical neurons.
The technique of retrograde labeling by the carbocyanine dye DiI (Godement et al., 1987) allows the study of a defined set of cortical pyramidal neurons, in this case the layer V cortico-collicular cells. Morphological features of pyramidal cell dendrites from saline-treated controls are similar to those of normal animals described previously (Miller, 1981; Juraska, 1982; DeFelipe and Farinas, 1992; Koester and O'Leary, 1992) , and the present data demonstrate that layer V pyramidal neurons display reduced dendritic branching and reduced numbers of spines in hemispheres that were exposed to the 192 IgG-saporin early in development.
For reasons stated above, we believe these morphological changes in cortical pyramidal cells are not due to general systemic effects, but rather due to loss of cholinergic afferents. The mechanisms through which cholinergic afferents could affect dendritic structure are currently unknown, but could include cholinergic transmitter-related activation, anterograde transport of an as yet unidentified trophic substance, or interaction with nitric oxide production in cortex (Vaucher et al., 1997) to suggest a few. Recent data from dissociated cell culture studies (Ha et al., 1997) have demonstrated that basal forebrain cells can enhance morphological features of a subset of cortical pyramidal neurons, providing in vitro corroboration of the present results.
Mechanisms of Dendritic Development
Studies of the mechanisms that regulate development of neuronal phenotype in general, and dendritic structure in particular, comprise an active field within contemporary neuroscience. Many studies have focused on the role of afferents, and a common approach has been to remove or reduce activity in an afferent system of interest and study the consequences of afferent removal (Valverde, 1967; Harris and Woolsey, 1981; Juraska, 1982; Lund et al., 1991; Annis et al., 1993 Annis et al., , 1994 . In those cases in which removal of afferents affects dendritic development, it is often not clear whether the removal of the afferent system retards development, halts development or induces atrophy. In the present case, the gradual development of differences between the 192 IgG-saporin-treated cases and the controls is suggestive of retarded development. Whether neurons from the experimental cases would eventually recover and develop all features similar to those of control cases cannot be answered at this point; however, the observation that treated cortical hemispheres remained reduced in size in animals as old as 3-6 months suggests a permanent effect.
Whether the reduced development in cortical neuronal morphological features results from a reduction of synaptic activity or reduction of some as yet unidentified trophic substance that results in lack of normal development of cortical neurons remains unknown. The latter possibility is intriguing in light of recent work by Katz and colleagues, who demonstrated important roles for neurotrophic factors in specific aspects of cortical pyramidal cell dendritic development (McAllister et al., 1995 (McAllister et al., , 1996 . Basal forebrain-derived cholinergic projections to cortex may play a role in modulating the expression of these putative neurotrophic factors. Recent data from experiments using a cell culture model demonstrate that basal forebrain cholinergic neurons can regulate differentiation of a particular subtype of cortical neurons in mixed cell cultures (Ha et al., 1997) and work is underway using slice and cell cultures to investigate possible mechanisms of this regulation.
Implications for Alzheimer's Disease
The neuropathology of Alzheimer's disease includes degeneration of cerebral cortical neurons and basal forebrain cholinergic neurons (Mesulam, 1990; Iraizoz et al., 1991; Cullen et al., 1997) . Whether cortical degeneration precedes or follows degeneration of basal forebrain neurons remains unclear, but evidence has been presented that indicates reciprocal trophic interactions between these two populations of neurons (Ha et al., 1996 (Ha et al., , 1997 . The evidence presented in this manuscript is consistent with the notion that basal forebrain cholinergic neurons can play a role in the development, and possibly the maintenance, of cortical neurons.
